Acute Myeloid Leukemia (AML)

Therapy for acute myeloid leukemia in older and unfit adults

Original Publication Date
Article Source
External Web Content
TITLE Azacitidine and venetoclax in previously untreated acute myeloid leukemia. AUTHORS DiNardo CD, Jonas BA, Pullarkat V, et al. JOURNAL The New England Journal of Medicine. 2020;383:617-629. doi: 10.1056/NEJMoa2012971. The therapy of acute myeloid leukemia (AML) has…

Hassan Alkhateeb, MD  

Institution
Mayo Clinic - Rochester
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelomonocytic Leukaemia (CMML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric

Alejandro Marinos Velarde, MD 

Institution
UT Southwestern Medical Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
About
Alejandro Marinos Velarde, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in allogeneic stem cell transplant and acute myeloid leukemia. Dr. Marinos Velarde earned his medical degree at the Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia in Lima, Peru. He completed a residency in internal medicine at Beaumont Hospital in Royal Oak, Michigan; a fellowship in hematology and oncology at the Baylor College of Medicine in Houston; and a fellowship in stem cell transplant and cellular therapy at MD

Afaf Osman, MD

Institution
University of Utah School of Medicine
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)

Pankit Vachhani, MD

Institution
University of Alabama Birmingham
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. Pankit Vachhani is an Assistant Professor of Medicine at the University of Alabama at Birmingham and Associate Scientist of Experimental Therapeutics. He graduated from Weill Cornell Medical College in Qatar in 2012 and on to complete his internal medicine residency at Virginia Commonwealth University, followed by a fellowship in hematology/oncology at Roswell Park Comprehensive Cancer Center in Buffalo, NY. Clinical Interests & Research: At UAB, he is involved in multiple clinical trials as a principal investigator. He leads the Leukemia/BMT working group. His primary research interest is

Risk prediction for clonal cytopenia: multicenter real-world evidence

Original Publication Date
Article Source
External Web Content
Key Points A 3-parameter CCRS model was devised specifically for patients diagnosed with clonal cytopenia. The CCRS offers precise CCUS risk assessment for patient management and clinical trial eligibility. Abstract Clonal cytopenia of undetermined significance (CCUS) represents…

What have we learned about TP53-mutated acute myeloid leukemia?

Original Publication Date
Article Source
External Web Content
Abstract TP53 is a tumor suppressor gene frequently mutated in human cancers and is generally associated with poor outcomes. TP53 mutations are found in approximately 5% to 10% of patients with de novo acute myeloid leukemia (AML), more frequently observed in elderly patients and…
Subscribe to Acute Myeloid Leukemia (AML)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.